Latest Regulatory Review News

Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.

Pilbara Minerals has delivered a robust start to FY26, boosting lithium production and revenue while cutting unit costs at its Pilgangoora operation. The company also advances key growth projects amid a volatile lithium market.

Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

RPMGlobal Holdings Limited has agreed to be acquired by Caterpillar Inc. through a Scheme of Arrangement valuing the company at over $1.1 billion, offering shareholders a 32.6% premium. The deal awaits regulatory and shareholder approvals, marking a significant consolidation in mining software technology.

Winsome Resources has resolved a regulatory hurdle to receive 17.65 million shares in Power Metals Corp, increasing its stake to 16.15% and reinforcing its position in critical minerals. Combined with a strong cash balance, this move strengthens Winsome’s liquidity and strategic outlook.

Burgundy Diamond Mines has disclosed a breach of ASX Listing Rule 10.1 related to $24.9 million in short-term financing involving related-party diamond sales. The company has halted these sales pending regulatory review and plans to seek shareholder approval.

Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.

Tamboran Resources is set to acquire Falcon Oil & Gas, creating a dominant player with approximately 2.9 million net prospective acres in Australia's Beetaloo Basin. The deal, valued at over US$500 million pro forma, aims to strengthen Tamboran's development footprint and shareholder base.

Southern Cross Media Group and Seven West Media have agreed to merge in an all-scrip deal, creating a dominant integrated TV, audio, and digital platform across Australia. The merger aims to unlock significant cost synergies and expand audience reach across metropolitan and regional markets.

Southern Cross Media Group and Seven West Media have agreed to merge, creating a dominant integrated TV, audio, and digital platform in Australia. The deal promises significant cost synergies and shareholder value accretion, pending regulatory and shareholder approvals.